Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension
2 other identifiers
interventional
70
1 country
1
Brief Summary
The planned intervention, entitled, Supporting Self-Management of Health Behaviors to Optimize Health (SMART-HABITS for Health), aims to provide support for patients with chronic kidney disease (CKD), hypertension and diabetes by providing text messages delivered as motivational reminders and support to encourage blood pressure self-monitoring through goal setting, customized task prompts via text message and feedback, leveraging social connections, and use of a gamification design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedStudy Start
First participant enrolled
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedDecember 18, 2025
December 1, 2025
1.4 years
July 5, 2022
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility: Adoption
Composite outcome determined by participant retention rate, total number of assessments performed by participants over complete study period; Good adoption will be determined by greater than or equal to 70 percent of those retained in the study, and greater than or equal to 70 percent of those enrolled who actually used SMART-HABITS-4-Health at least one time as measured by data usage statistics.
Collected throughout study (8 weeks)
Feasibility: Adherence
Determined by the number of blood pressure assessments performed divided by the number of assessments recommended. Good adherence will be determined by greater than or equal to 70 percent performed out of the recommended.
Collected throughout study (8 weeks)
Feasibility: Acceptability of SMART-HABITS-4-Health
Determined through satisfactory ratings system usability scale survey (score above 68)
collected at 4 weeks
Feasibility: Acceptability of SMART-HABITS-4-Health
Determined through satisfactory ratings system usability scale survey (score above 68)
collected at 8 weeks
Feasibility: Acceptability of SMART-HABITS-4-Health
Determined by inductive qualitative analysis from semi-structured interviews with study participants after the end of the pilot study. There is no a priori set up codes or scales to assess this outcome as it is purely a qualitative outcome.
Collected with 12 weeks of study completion
Secondary Outcomes (9)
Social Incentive Effectiveness
8 weeks
CKD Knowledge
8 weeks
Self-Efficacy
8 weeks
Chronic Disease Self-Management
8 weeks
Disease Related Quality of Life
8 weeks
- +4 more secondary outcomes
Study Arms (2)
Support Person
EXPERIMENTALA support person not in the study will receive the participant's weekly blood pressure performance details and will contact them at least on a weekly basis to encourage continued blood pressure monitoring. Prior to randomization, the participant will select a preference between a support person that is close to them (e.g., friend or family member) or a support person who is provided by the study, a Peer Mentor.
Social Norms
EXPERIMENTALIn this arm, participants will be texted reports of blood pressure performance statistics of the other participants in the study and also receive weekly feedback about how their blood pressure information compares to others in the study. Participants in this arm will have access to a leaderboard that displays this information.
Interventions
Prior to randomization, participants will select their preference of the type of support person if they are assigned to this arm 1) a person they have close relationship with, or 2) a Peer Mentor, an individual who has successfully monitored their blood pressure at home using the study's equipment and also has diabetes, kidney disease, and high blood pressure. The Peer Mentor works with the research study team. This will be provided with the same weekly blood pressure feedback that the participants will receive. The support person is encouraged to reach out to the participant at least weekly.
Participants will receive weekly text messages that includes their individualize blood pressure performance statistics, included frequency of blood pressure monitoring and average blood pressure, and compare it to goals provided at the beginning of the study, as well as the week prior. Participants will also has access to a leaderboard that displays blood pressure performance information all people in the study in an anonymous fashion.
Eligibility Criteria
You may qualify if:
- diagnosis of chronic kidney disease (any stage), hypertension, diabetes
- followed at University of Pennsylvania nephrology practice
- aged 18 years or over. -
- own a smart device (smartphone or tablet) capable of connecting to the internet and has Bluetooth enabled technology
- able to comprehend English.
- a mean blood pressure reading of \<180/100 mmHg in person study visit
- able and willing to provide informed consent
You may not qualify if:
- inability to provide consent or read or speak English
- inability to self-monitor (e.g., diagnosis of dementia, cognitive impairment, physically unable to set up BP cuff and machine)
- already participating in another blood pressure study or intervention trial
- vulnerable populations, living in a long-term care or rehabilitation institution,
- if likely to have their care transferred to another facility outside participating clinic areas during the course of the study
- planning to travel or live consecutively out of the country for more than one month
- mean blood pressure reading of \>180/100 mmHg at in person study visit
- hypertension not managed by the nephrologist in Penn Medicine
- any other reason they do not expect to be able to complete the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Schrauben, MD, MSCE
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2022
First Posted
October 4, 2022
Study Start
August 21, 2023
Primary Completion
January 31, 2025
Study Completion
March 31, 2025
Last Updated
December 18, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share